Search

everythinglearnresearchcommunity

for

Search:↓

Adolescents with severe alopecia incur significantly higher healthcare costs.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Blocking certain immune signals can reduce skin damage from radiation therapy.

RTA 408 cream protects mice from radiation skin damage.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

African plants may help treat cancer by boosting immunity and protecting cells.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Mild oxidative stress can prevent hair loss from chemotherapy.

TS-13 speeds up hair regrowth after chemotherapy.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.